A carregar...

Therapeutic approaches to target alpha-synuclein pathology

Starting two decades ago with the discoveries of genetic links between alpha-synuclein and Parkinson’s disease risk and the identification of aggregated alpha-synuclein as the main protein constituent of Lewy pathology, alpha-synuclein has emerged as the major therapeutic target in Parkinson’s disea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Neurol
Main Authors: Brundin, Patrik, Dave, Kuldip D., Kordower, Jeffrey H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6541231/
https://ncbi.nlm.nih.gov/pubmed/28987463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2017.10.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!